Mitobrin (Tobramycin)

Tobramycin, the active ingredient in Mitobrin, is an aminoglycoside antibiotic presented as a topical ear preparation for auricular use. It is employed to treat bacterial infections of the external ear canal, such as otitis externa, in patients of all ages. GNH USA supplies Mitobrin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mitobrin, an aminoglycoside antibiotic, is used to manage bacterial infections of the external ear.

Otitis externa: reduces bacterial load and promotes resolution of infection. External ear canal infection: eliminates pathogenic bacteria and alleviates symptoms. Swimmer's ear: provides targeted antimicrobial activity to clear infection and prevent complications.

Adverse reactions may occur with auricular use of Mitobrin. Patients should be monitored for any signs of local or systemic toxicity.

Common Side Effects: - Ear discomfort or mild pain - Itching or burning sensation in the ear canal - Redness or mild inflammation of the external ear - Temporary hearing changes - Ear discharge - Mild dizziness

Serious or Rare Side Effects: - Ototoxicity leading to permanent hearing loss or balance disturbance - Allergic reactions such as rash, swelling, or anaphylaxis - Nephrotoxicity from systemic absorption - Severe vestibular dysfunction

Mitobrin should be used with caution and under professional supervision. - Renal impairment: assess kidney function before use. - Pre‑existing hearing loss: monitor auditory function closely. - Pregnancy: avoid unless clearly indicated by a physician. - Concomitant ototoxic drugs: evaluate risk of additive toxicity. - Allergic history: confirm no known hypersensitivity to aminoglycosides. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Potential drug interactions may affect safety or efficacy of Mitobrin.

Major Interactions (Avoid): - Loop diuretics (e.g., furosemide): increased risk of ototoxicity. - Other aminoglycosides: additive nephro‑ and ototoxic effects. - Muscle relaxants (e.g., pancuronium): enhanced neuromuscular blockade. - Vancomycin: combined ototoxic potential.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): possible renal stress. - ACE inhibitors: monitor renal function. - Other nephrotoxic agents (e.g., amphotericin B): watch for kidney injury. - Diuretics other than loops: adjust dosing if needed. - Radiographic contrast media: assess renal status before use.